The Menges Group

Skip to Content

s - Skip to Content
0 - Access key details
1 - Back to top
2 - Header search

Our projects support the evolution of coordinated care programs that improve the quality of life and lower expenditures for high-need Medicaid and Medicare beneficiaries.

What We Do

The Menges Group partners with Medicaid-focused organizations to improve performance, policy, and operations.

Business Development Strategy and Proposal Support
Data Analytics and Products
Operational Support for Managed Care Optimization
Public Policy Analyses

Business Development Strategy and Proposal Support

The Menges Group helps our clients win state Medicaid procurements, meaning we help our clients exist. We assist with several procurements annually, and the majority of our clients not only earn a contract award, they score first or second.

Learn More About This Service

Our Team

Joel Menges

Chief Executive Officer

Amira Mouna

Founding Partner

Poornima Singh

Founding Partner

Jessica Wiecezak

Founding Partner

Taryn Nader

Managing Director

Grace Bernstein

Director

Veronica Sever

Director

Christie Ahn

Managing Consultant

Emalee Barto

Managing Consultant

Manisha Gupta

Managing Consultant

Courtney Pfeifer

Managing Consultant

Clarissa Flanegin

Managing Consultant

Grace Hong

Managing Consultant

Melissa Atlas

Senior Consultant

Hannah Jin

Senior Consultant

Anastasia Johnson

Senior Consultant

Haley Quinn

Senior Consultant

Juhi Sharma

Senior Consultant

Madeline Walters

Managing Consultant

Mint Dalton

Senior Consultant

Danielle Shapero

Consultant

Erin Gaul

Research Consultant

Phyllis Call

Office Administrator

prev

next

Visit our staff page

5-Slide Series

Recent Trends in Gun Deaths

As the final update of our 2024 mini-series, this edition analyzes trends in suicides, homicides, and the role of firearms.

Read more Volume 135

Assessment of NCQA Medicaid MCO Quality Ratings Across the Two Most Recent Measurement Years

This edition assesses changes and trends in NCQA Medicaid MCO quality ratings across measurement years 2023 and 2024.

Read more Volume 134

Timeline of Key Medicaid Provisions in One Big Beautiful Bill Act (OBBBA)

This edition summarizes major Medicaid changes in OBBBA, organized by implementation timeline, from 2025 to 2030. Key provisions introduce changes to eligibility, benefits, and state financing.

Read more Volume 133

Medicaid Expenditure Progression, 2013 – 2023

This edition quantifies the progression of Medicaid costs from 2013-2023 with a focus on the federal/state share of costs. Data are shown nationally, for each state and territory, and for various state groupings (regional, political, and by Medicaid Expansion adoption).

Read more Volume 132

Medicaid Expansion’s Impact on Prescription Drug Access

This edition examines the impact of Medicaid Expansion on prescription drug access, comparing prescription volume trends in 18 states that expanded Medicaid in 2014 with six non-expansion states. We look at overall prescription volume as well as three specific therapeutic classes of drugs: antidepressants, insulin, and bronchodilators. Over the 10-year…

Read more Volume 131

PACE Landscape

This edition provides an overview of the PACE model, which delivers comprehensive, community-based care for adults aged 55+ who need nursing home-level of care. As of March 2025, 184 organizations operate over 300 PACE centers in 33 states and DC, serving 82,000 participants—most of whom are dually eligible and…

Read more Volume 130

Analyzing Medicaid’s Role in Redistributing Taxpayer Dollars Across States

This edition provides information on Medicaid’s fiscal redistributional dynamics. For example, during FFY2023 Trump-won states collectively gained $16.8 billion between the amounts residents of these states contributed to Medicaid (via their Federal and state taxes) and the level of Medicaid spending that took place in their states. …

Read more Volume 129

5 Slide Mini-Series Edition #2: Medicaid Coverage Renewals and Terminations– Overview and Key Trends

The second edition of our Medicaid Unwinding and Redeterminations 5 Slide Mini-Series explores Medicaid coverage renewal outcomes across states during the unwinding period (March 2023- July 2024).

Read more Volume 128

5 Slide Mini-Series Edition #1: Medicaid Unwinding and Redeterminations

This first edition of our Medicaid Unwinding and Redeterminations 5 Slide Mini-Series provides an overview of Medicaid eligibility and enrollment trends during and after the COVID-19 public health emergency (PHE).

Read more Volume 127

Assessment of NCQA Medicaid MCO Quality Ratings Across Performance Years 2022 and 2023

This edition delves into NCQA’s Medicaid health plan overall quality ratings for performance years 2022 and 2023. A key component of our analyses involved creating enrollment weighted average scores for the Medicaid health plans operating in multiple states, and similar average scores across the health plans serving Medicaid in…

Read more Volume 126

prev

next

View the full series

Recent Publications

Assessment of HealthChoices, Pennsylvania’s Medicaid Managed Care Program

In this report and its accompanying summary documents, we evaluate the Physical HealthChoices program’s performance across areas such as quality outcomes, cost management, collaboration between Pennsylvania’s Medicaid agency and the MCOs, community investments, provider partnerships, and initiatives addressing social determinants…

Keywords: Medicaid

Assessment of the Pharmacy Carve-In Model for Utah’s Medicaid Program

Utah’s Medicaid program contracts with four Accountable Care Organizations (ACOs) to coordinate care for most of the state’s Medicaid enrollees. This October 2024 report examines the fiscal and programmatic impacts that transitioning to a prescription drug carve-out model, where the pharmacy benefit would be managed under a single-payer system…

Keywords: Pharmacy Carve Out, Prescription Drugs

Assessment of the Pharmacy Carve-In Model for Virginia’s Medicaid Program

This report explores the fiscal and programmatic impacts that a switch to a prescription drug carve-out model, where the pharmacy benefit would be managed under a single-payer system within Medicaid using the fee-for-service payment methodology, would have on Virginia’s Medicaid program (Cardinal Care). Our key recommendations for the Medicaid…

Keywords: Pharmacy Carve Out, Prescription Drugs

Assessment of Washington State’s Medicaid Prescription Drug Management Performance and Policy Options

This report explores which prescription drug model is best suited for Washington’s Apple Health (Medicaid) program: the current carve-in prescription drug model, under which managed care organizations (MCOs) pay for members’ prescriptions, or a carve out model, where prescriptions are managed by a separate company using a fee-for service…

Keywords: Expenditures, Medicaid, Pharmacy Carve Out, Prescription Drugs

Costs and Benefits of Enhancing Private Duty/Shift Nursing Payment Rates in Pennsylvania’s Medicaid Program

This report was enlisted by the Pennsylvania Homecare Association to evaluate the need for enhancing Pennsylvania’s Medicaid Private Duty Nursing (PDN) payment rates. Through a mixture of quantitative analyses and real-life patient examples, this report highlights the anticipated benefits this PDN rate increase is projected to yield.

Keywords: Expenditures, Medicaid, Policy

Costs and Benefits of Enhancing Private Duty Nursing Payment Rates in Colorado’s Medicaid Program

This report was commissioned by the Home Care and Hospice Association of Colorado. The report derives the Medicaid payment rate increase needed to attract adequate private duty nursing (PDN) service capacity in Colorado. We’ve estimated the cost to the Medicaid agency these rate increases will create –…

Keywords: Expenditures, Medicaid, Policy

Trends in Opioid and Medication-Assisted Treatment Prescription Drug Usage in Medicaid

This report describes trends in opioid and medication-assisted treatment (MAT) prescription drug usage in Medicaid, put together for a presentation at a recent opioid conference.

Keywords: Medicaid, Prescription Drugs

Medicaid Prescription Drug Management: Quality Scores Compared Across Different Approaches

The Elevance Health Public Policy Institute engaged and worked with us to assess the degree to which quality scores on pharmacy-related measures were affected by the state’s Medicaid managed care program design features. The key issue assessed was whether quality scores were better in states where the prescription…

Keywords: Pharmacy Carve Out, Policy, Quality

Medication Adherence in Medicaid

Building upon our 2014 report titled Prescription Drug Adherence in Medicaid Managed Care, this report provides updated analyses performed on medication adherence, assesses the impacts of Medicaid expansion and the COVID-19 pandemic on medication adherence, and offers recommendations for further improvement to Medicaid medication access and adherence.

Keywords: COVID-19, Medicaid, Policy, Prescription Drugs

Medicaid Prescription Drug Benefit Management: Performance Comparison Across Different State Policy Approaches

States that employ Medicaid managed care organizations (MCOs) to pay for prescription drugs outperform states that rely on the fee-for-service (FFS) setting to control drug costs. Despite larger rebates in FFS, MCOs’ effective strategies to encourage…

Keywords: Expenditures, Medicaid, Prescription Drugs

Assessment of HealthChoices, Pennsylvania’s Medicaid Managed Care Program

In this report and its accompanying summary documents, we evaluate the Physical HealthChoices program’s performance across areas such as quality outcomes, cost management, collaboration between Pennsylvania’s Medicaid agency and the MCOs, community investments, provider partnerships, and initiatives addressing social determinants…

Keywords: Medicaid

Assessment of the Pharmacy Carve-In Model for Utah’s Medicaid Program

Utah’s Medicaid program contracts with four Accountable Care Organizations (ACOs) to coordinate care for most of the state’s Medicaid enrollees. This October 2024 report examines the fiscal and programmatic impacts that transitioning to a prescription drug carve-out model, where the pharmacy benefit would be managed under a single-payer system…

Keywords: Pharmacy Carve Out, Prescription Drugs

Assessment of the Pharmacy Carve-In Model for Virginia’s Medicaid Program

This report explores the fiscal and programmatic impacts that a switch to a prescription drug carve-out model, where the pharmacy benefit would be managed under a single-payer system within Medicaid using the fee-for-service payment methodology, would have on Virginia’s Medicaid program (Cardinal Care). Our key recommendations for the Medicaid…

Keywords: Pharmacy Carve Out, Prescription Drugs

Assessment of Washington State’s Medicaid Prescription Drug Management Performance and Policy Options

This report explores which prescription drug model is best suited for Washington’s Apple Health (Medicaid) program: the current carve-in prescription drug model, under which managed care organizations (MCOs) pay for members’ prescriptions, or a carve out model, where prescriptions are managed by a separate company using a fee-for service…

Keywords: Expenditures, Medicaid, Pharmacy Carve Out, Prescription Drugs

Costs and Benefits of Enhancing Private Duty/Shift Nursing Payment Rates in Pennsylvania’s Medicaid Program

This report was enlisted by the Pennsylvania Homecare Association to evaluate the need for enhancing Pennsylvania’s Medicaid Private Duty Nursing (PDN) payment rates. Through a mixture of quantitative analyses and real-life patient examples, this report highlights the anticipated benefits this PDN rate increase is projected to yield.

Keywords: Expenditures, Medicaid, Policy

Costs and Benefits of Enhancing Private Duty Nursing Payment Rates in Colorado’s Medicaid Program

This report was commissioned by the Home Care and Hospice Association of Colorado. The report derives the Medicaid payment rate increase needed to attract adequate private duty nursing (PDN) service capacity in Colorado. We’ve estimated the cost to the Medicaid agency these rate increases will create –…

Keywords: Expenditures, Medicaid, Policy

Trends in Opioid and Medication-Assisted Treatment Prescription Drug Usage in Medicaid

This report describes trends in opioid and medication-assisted treatment (MAT) prescription drug usage in Medicaid, put together for a presentation at a recent opioid conference.

Keywords: Medicaid, Prescription Drugs

Medicaid Prescription Drug Management: Quality Scores Compared Across Different Approaches

The Elevance Health Public Policy Institute engaged and worked with us to assess the degree to which quality scores on pharmacy-related measures were affected by the state’s Medicaid managed care program design features. The key issue assessed was whether quality scores were better in states where the prescription…

Keywords: Pharmacy Carve Out, Policy, Quality

Medication Adherence in Medicaid

Building upon our 2014 report titled Prescription Drug Adherence in Medicaid Managed Care, this report provides updated analyses performed on medication adherence, assesses the impacts of Medicaid expansion and the COVID-19 pandemic on medication adherence, and offers recommendations for further improvement to Medicaid medication access and adherence.

Keywords: COVID-19, Medicaid, Policy, Prescription Drugs

Medicaid Prescription Drug Benefit Management: Performance Comparison Across Different State Policy Approaches

States that employ Medicaid managed care organizations (MCOs) to pay for prescription drugs outperform states that rely on the fee-for-service (FFS) setting to control drug costs. Despite larger rebates in FFS, MCOs’ effective strategies to encourage…

Keywords: Expenditures, Medicaid, Prescription Drugs

prev

next

View all reports

Interested In Learning How The Menges Group Can Help?

Please complete the form on this page.

Someone from our team will promptly respond back to your inquiry!

By submitting this form, you are consenting to receive marketing emails from: The Menges Group, 4001 9th St N #227, Arlington, VA, 22203, www.themengesgroup.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact